DBV Technologies | DBVT - Trade Debtors


DBV Technologies reported $15.97M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Amarin USD 127.31M 8.18M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
DBV Technologies USD 15.97M 279K Sep/2025
Halozyme Therapeutics USD 346.04M 29.7M Sep/2025
Incyte USD 895.89M 53M Sep/2025
Insmed USD 65.26M 10.23M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
Neurocrine Biosciences USD 728M 132.3M Sep/2025
PTC Therapeutics USD 203.07M 6.94M Sep/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
United Therapeutics USD 297.7M 81.6M Sep/2025